Literature DB >> 22533722

Reanalysis of methamphetamine dependence treatment trial.

Celia Winchell, Bob A Rappaport, Rigoberto Roca, Curtis J Rosebraugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22533722      PMCID： PMC6493494          DOI： 10.1111/j.1755-5949.2011.00288.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  29 in total

Review 1.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

2.  Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.

Authors:  Katherine A McDermott; Margaret L Griffin; Hilary S Connery; E Yvette Hilario; David A Fiellin; Garrett M Fitzmaurice; Roger D Weiss
Journal:  J Clin Psychiatry       Date:  2015-02       Impact factor: 4.384

3.  Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.

Authors:  André Q C Miguel; Brian D Kiluk; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2019-03-20       Impact factor: 4.492

4.  What happens in treatment doesn't stay in treatment: cocaine abstinence during treatment is associated with fewer problems at follow-up.

Authors:  Brian D Kiluk; Charla Nich; Katie Witkiewitz; Theresa A Babuscio; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2014-03-17

5.  Adjustment for Variable Adherence Under Hierarchical Structure: Instrumental Variable Modeling Through Compound Residual Inclusion.

Authors:  Tyson H Holmes; Donna M Zulman; Clete A Kushida
Journal:  Med Care       Date:  2016-01-13       Impact factor: 2.983

Review 6.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

7.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526

8.  Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

Authors:  Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Yih-Ing Hser; Gregory M Lucas; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2019-09-04       Impact factor: 4.492

Review 9.  Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.

Authors:  Brian D Kiluk; Kathleen M Carroll; Amy Duhig; Daniel E Falk; Kyle Kampman; Shengan Lai; Raye Z Litten; David J McCann; Ivan D Montoya; Kenzie L Preston; Phil Skolnick; Constance Weisner; George Woody; Redonna Chandler; Michael J Detke; Kelly Dunn; Robert H Dworkin; Joanne Fertig; Jennifer Gewandter; F Gerard Moeller; Tatiana Ramey; Megan Ryan; Kenneth Silverman; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

10.  Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome.

Authors:  Brian D Kiluk; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2017-08-14       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.